These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 40027)

  • 1. Conformational analogues of dopamine. Synthesis and pharmacological activity of (E)- and (Z)-2-(3,4-dihydroxyphenyl)cyclopropylamine hydrochlorides.
    Erhardt PW; Gorczynski RJ; Anderson WG
    J Med Chem; 1979 Aug; 22(8):907-11. PubMed ID: 40027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (+/-)(E)-2-(3,4-Dihydroxyphenyl)cyclopropylamine hydrochloride (ASL-7003): a rigid analogue of dopamine.
    Borgman RJ; Erhardt PW; Gorczynski RJ; Anderson WG
    J Pharm Pharmacol; 1978 Mar; 30(3):193-4. PubMed ID: 24699
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and renal vasodilator activity of 2-chlorodopamine and N-substituted derivatives.
    McCarthy JR; McCowan J; Zimmerman MB; Wenger MA; Emmert LW
    J Med Chem; 1986 Sep; 29(9):1586-90. PubMed ID: 3528490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational requirements for dopamine-induced vasodilation.
    Volkman PH; Kohli JD; Goldberg LI; Cannon JG; Lee T
    Proc Natl Acad Sci U S A; 1977 Aug; 74(8):3602-6. PubMed ID: 269416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the cardiac stimulant properties of (3,4-dihydroxyphenyl)-cyclopropylamine (ASL-7003) and 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (A6,7DTN).
    Gorczynski RJ; Anderson WG; Erhardt PW; Stout DM
    J Pharmacol Exp Ther; 1979 Aug; 210(2):252-8. PubMed ID: 222894
    [No Abstract]   [Full Text] [Related]  

  • 6. [Synthesis and cardiovascular activities of peptidyl dopamine derivatives].
    Gao DM; Yang FQ; Chen GL; Cheng WY; Chen JC; Min Y; Shang HM; Zhang SA
    Yao Xue Xue Bao; 1989; 24(6):422-30. PubMed ID: 2609981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational study oof catecholamine receptor sites. 7. Syntheses of erythro- and threo-3-amino-2-(3,4-dihydroxyphenyl)-2-butanol hydrochlorides and erythro- and threo-2-amino-3-(3,4-dihydroxyphenyl)butane hydrochlorides.
    Smissman EE; Borchardt RT
    J Med Chem; 1971 Aug; 14(8):702-7. PubMed ID: 5114066
    [No Abstract]   [Full Text] [Related]  

  • 8. Rigid analogues of dopamine: synthesis and interaction of 6-exo- and 6-endo-(3',4'-dihydroxyphenyl)-2-azabicyclo[2.2.2]octanes with dopamine uptake sites and receptors.
    Law SJ; Morgan JM; Masten LW; Borne RF; Arana GW; Kula NS; Baldessarini RJ
    J Med Chem; 1982 Mar; 25(3):213-6. PubMed ID: 7069700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and peripheral cardiovascular action of cis- and trans-2-(3,4-dimethoxybenzyl)cyclopentylamine hydrochlorides.
    Teller SR; Jarboe CH
    J Med Chem; 1982 Mar; 25(3):227-31. PubMed ID: 7069702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homologs of dopa, alpha-methyldopa, and dopamine as potential cardiovascular drugs.
    Winn M; Rasmussen R; Minard F; Kyncl J; Plotnikoff N
    J Med Chem; 1975 Apr; 18(4):434-7. PubMed ID: 1079053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Isopropyl derivatives of dopamine and 5,6-dihydroxy-2-aminotetralin.
    Cannon JG; O'Donnell JP; Lee T; Hoppin CR; Long JP; Ilhan M; Costall B; Naylor RJ
    J Med Chem; 1975 Dec; 18(12):1212-6. PubMed ID: 497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congeners of the beta conformer of dopamine derived from cis- and trans-octahydrobenzo[f]quinoline and trans-octahydrobenzo[g]quinoline.
    Cannon JG; Lee T; Goldman HD; Long JP; Flynn JR; Verimer T; Costall B; Naylor RJ
    J Med Chem; 1980 Jan; 23(1):1-5. PubMed ID: 7188974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and biological actions of N-2,2,2-trifluoroethyl-2-(3,4-dihydroxyphenyl)ethylamine.
    O'Donnell JP; Azzaro AJ; Urquilla PR
    J Pharm Sci; 1980 Feb; 69(2):149-52. PubMed ID: 7359313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine agonists: effects of charged and uncharged analogues of dopamine.
    Chang YA; Ares J; Anderson K; Sabol B; Wallace RA; Farooqui T; Uretsky N; Miller DD
    J Med Chem; 1987 Jan; 30(1):214-8. PubMed ID: 3806598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational requirements for vascular alpha-adrenergic activity.
    Kohli JD; Volkman PH; Goldberg LI; Cannon JG
    Proc Soc Exp Biol Med; 1978 May; 158(1):28-31. PubMed ID: 26920
    [No Abstract]   [Full Text] [Related]  

  • 16. Arrhythmogenic potential of dopexamine hydrochloride during halothane anaesthesia in dogs.
    Neustein SM; Dimich I; Sampson I; Sadeghi A; Mezrow C; Shiang H
    Can J Anaesth; 1994 Jun; 41(6):542-6. PubMed ID: 7915210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actions of a dopaminergic and beta 2-adrenergic agonist on O2 extraction by canine skeletal muscle.
    Cain SM; Bredle DL
    Adv Exp Med Biol; 1990; 277():569-75. PubMed ID: 1982916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular and renal actions of dopamine: potential clinical applications.
    Goldberg LI
    Pharmacol Rev; 1972 Mar; 24(1):1-29. PubMed ID: 4554480
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological characterization of dopamine-4-O-sulfate.
    Ackerman DM; Hieble JP; Sarau HM; Jain TC
    Arch Int Pharmacodyn Ther; 1984 Feb; 267(2):241-8. PubMed ID: 6712357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and pharmacological evaluation of sulfonium analogues of dopamine: nonclassical dopamine agonists.
    Anderson K; Kuruvilla A; Uretsky N; Miller DD
    J Med Chem; 1981 Jun; 24(6):683-7. PubMed ID: 7252978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.